現在の治療の限界

Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis.

QJM : monthly journal of the Association of Physicians·2011

Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study.

Thorax·2006

Effects of inhaled corticosteroids on bone.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2005

Survival and disease progression in UK patients with lymphangioleiomyomatosis.

Thorax·2004

Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial.

Lancet (London, England)·2004

Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide.

Thorax·2003

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

An herbal formula alleviates hyperuricemia: Evidence from network pharmacology and in vivo experiments.

Combinatorial chemistry & high throughput screening·2026

Behavioral and Molecular Effects of Kamikihito and Mesenchymal Stem Cells in a Two-hit Model of Treatment-resistant Depression.

Current neuropharmacology·2026

Effect of Educational and Behavioral Interventions on Medication-Overuse Headache: A Systematic Review and Meta-Analysis.

Pain research & management·2026

Diffusion tensor imaging in chronic tension-type headache.

Frontiers in pain research (Lausanne, Switzerland)·2026

Multidimensional therapeutic advantages of Smilax glabra (Tufuling)-containing formulae in gout: an integrated Systematic Review and network pharmacology-based prediction.

Frontiers in endocrinology·2026

Evaluating combined acupuncture and antiresorptive therapy in Chinese women with postmenopausal osteoporosis: a systematic review and network meta-analysis.

Frontiers in endocrinology·2026

関連する実験動画

現在の治療の限界

関連する概念動画

Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis.

Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study.

Effects of inhaled corticosteroids on bone.

Survival and disease progression in UK patients with lymphangioleiomyomatosis.

Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial.

Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

An herbal formula alleviates hyperuricemia: Evidence from network pharmacology and in vivo experiments.

Behavioral and Molecular Effects of Kamikihito and Mesenchymal Stem Cells in a Two-hit Model of Treatment-resistant Depression.

Effect of Educational and Behavioral Interventions on Medication-Overuse Headache: A Systematic Review and Meta-Analysis.

Diffusion tensor imaging in chronic tension-type headache.

Multidimensional therapeutic advantages of Smilax glabra (Tufuling)-containing formulae in gout: an integrated Systematic Review and network pharmacology-based prediction.

Evaluating combined acupuncture and antiresorptive therapy in Chinese women with postmenopausal osteoporosis: a systematic review and network meta-analysis.

関連する実験動画

現在の治療の限界

関連する概念動画

関連記事